cp wire

CP Wire Articles

BeiGene Presents Encouraging Results in Ph I Trial of Tislelizumab in Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
  • The objective response rate was 29 percent (4 of 22 patients)
  • BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in solid tumor... read more
Thu, 09/20/18 - 09:47 am
Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
  • Amicus will make an upfront cash payment of $100 million
  • The company also announced closing a $150 million term loan to help finance the acquisition and development costs
  • ... read more
Thu, 09/20/18 - 09:31 am
Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
  • The vaccine was awarded fast-track status by the FDA in October of 2017
  • Pfizer expects to start Phase 3 trials in a few months


Pfizer Inc. (NYSE:PFE) announced on 9/... read more

Thu, 09/20/18 - 09:08 am
MaaT Pharma Presents Analysis of Its First-in-Class High Diversity Microbiome Therapeutic

MaaT Pharma announced on 9/18/19 the presentation of the analysis of MaaT Pharma’s lead biotherapeutic, MaaT013, demonstrating its drug product characteristics using MaaT Pharma’s proprietary big... read more

Wed, 09/19/18 - 10:57 pm
Argenx To Raise $300 million in U.S. public offering
  • argynx has 8 drugs in development
  • Partners include Abbvie, LEO Pharma, and Staten Biotech

argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company... read more

Wed, 09/19/18 - 09:32 am

Pages